MamtaK(Khandelwal)JainMD

Infectious Disease • Dallas, TX

HIV/AIDS Medicine

Professor, Internal Medicine, University of Texas Southwestern Medical Center, Southwestern Medical School

Join to view full profile

Dr. Jain is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Jain's full profile

Already have an account?

Office
5323 Harry Hines Boulevard
Dallas, TX 75390
Phone+1 214-645-2800

Fax+1 214-645-2808
Is this information wrong?

Education & Training

University of Texas Southwestern Medical CenterFellowship, Infectious Disease, 1999 - 2002
Baylor College of MedicineResidency, Internal Medicine, 1996 - 1999
Baylor College of MedicineClass of 1996

Certifications & Licensure

TX State Medical License 1997 - 2024
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

Board of Directors HIV MA

Clinical Trials

Prospective Observational Epidemiologic Study of Maraviroc's Safety Start of enrollment: 2008 Mar 31
Completed
Long-term Observational Study in HIV Subjects Exposed to EGRIFTA® Start of enrollment: 2013 Feb 01
Terminated
Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA® Start of enrollment: 2012 Jun 01
Terminated
Phase 4
HBV-HIV Coinfection Research Network Start of enrollment: 2014 Apr 01
Completed
Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Regimen Versus Boosted Protease Inhibitor (bPI) Along With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Regimen in Virologically-Suppressed, HIV-1 Infected Participants Start of enrollment: 2015 Mar 01
Completed
Phase 3
Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza Start of enrollment: 2015 Jan 01
Completed
Phase 3
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults Start of enrollment: 2015 Mar 26
Completed
Phase 3
Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients Start of enrollment: 2015 Feb 23
Active, not recruiting
Phase 3
Safety and Efficacy of a Switch to Doravirine, Tenofovir, Lamivudine (MK-1439A) in Human Immunodeficiency Virus (HIV-1)-Infected Participants Virologically Suppressed on an Anti-retroviral Regimen in Combination With Two Nucleoside Reverse Transcriptase Inhibitors (MK-1439A-024) Start of enrollment: 2015 Jun 09
Completed
Phase 3
Comparing the Efficacy and Safety of High-Titer Versus Low-Titer Anti-Influenza Immune Plasma for the Treatment of Severe Influenza A Start of enrollment: 2015 Nov 01
Completed
Phase 3
Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Abacavir/Dolutegravir/Lamivudine in Human Immunodeficiency Virus-1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults Start of enrollment: 2015 Nov 13
Completed
Phase 3
Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in Human Immunodeficiency Virus (HIV-1) Infected, Antiretroviral Treatment-Naive Adults Start of enrollment: 2015 Nov 11
Completed
Phase 3
Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S. Start of enrollment: 2015 Dec 01
Completed
Not Applicable
Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV Treatment Start of enrollment: 2016 Apr 01
Completed
Phase 3
Atovaquone for Treatment of COVID-19 Start of enrollment: 2020 Jul 22
Completed
Phase 2
Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV Patients Start of enrollment: 2005 Sep 01
Completed
Outpatient Treatment With Anti-Coronavirus Immunoglobulin Start of enrollment: 2021 Aug 06
Recruiting
Phase 3
Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) Study Start of enrollment: 2016 Feb 25
Terminated
Phase 4
Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19) Start of enrollment: 2020 Mar 06
Completed
Phase 3
Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment Start of enrollment: 2020 Mar 15
Completed
Phase 3
Vaccination for Recovered Inpatients With COVID-19 (VATICO) Start of enrollment: 2021 Aug 25
Completed
Phase 4
ACTIV-2: A Study for Outpatients With COVID-19 Start of enrollment: 2020 Aug 19
Completed
Phase 2, Phase 3
Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19 Start of enrollment: 2020 Mar 18
Completed
Phase 2, Phase 3
ACTIV-3: Therapeutics for Inpatients With COVID-19 Start of enrollment: 2020 Aug 04
Completed
Phase 3
Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC) Start of enrollment: 2020 Oct 08
Completed
Phase 3
Adaptive COVID-19 Treatment Trial 4 (ACTT-4) Start of enrollment: 2020 Dec 02
Completed
Phase 3
Adaptive COVID-19 Treatment Trial 3 (ACTT-3) Start of enrollment: 2020 Aug 05
Completed
Phase 3
Adaptive COVID-19 Treatment Trial 2 (ACTT-2) Start of enrollment: 2020 May 08
Completed
Phase 3
A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications Start of enrollment: 2018 Jan 21
Terminated
Phase 3
A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection Start of enrollment: 2018 Jan 03
Terminated
Phase 3
Join now to see all

Publications & Presentations

PubMed

Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19.
Aggarwal, N., Nordwall, J., Braun, D., Chung, L., Coslet, J., Der, T., Eriobu, N., Ginde, A., Hayanga, A., Highbarger, H., Holodniy, M., Horcajada, J., Jain, M., Kim, ...> ;Clinical Infectious Diseases. 2024 Feb 20
Persistent CMV pneumonitis in HIV infection: a case report.
Abbye W Frederick, Ellen Kitchell, Clare McCormick-Baw, Vishal Kukkar, Mamta K Jain> ;BMC Infectious Diseases. 2023 Nov 29
15 citations
Severe Mpox Infections in People With Uncontrolled Human Immunodeficiency Virus.
Anusha Govind, Susana M Lazarte, Ellen Kitchell, Jeremy Y Chow, Carolee D Estelle, Emma Fixsen, Caitlin Helm, Mamta K Jain, Roma Mehta, Trish M Perl, Jaini M Sutaria, ...> ;Clinical Infectious Diseases. 2023 May 24
2 citations
Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment ...
Gail E Potter, Tyler Bonnett, Kevin Rubenstein, David A Lindholm, Rekha R Rapaka, Sarah B Doernberg, David C Lye, Richard A Mularski, Noreen A Hynes, Susan Kline, Cath...> ;Annals of Internal Medicine. 2022 Dec 1
24 citations
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19.
Holodniy, M., , Rogers, A., Wentworth, D., Phillips, A., Shaw-Saliba, K., Dewar, R., Aggarwal, N., Babiker, A., Chang, W., Dharan, N., Davey, V., Higgs, E., Gerry, N.,...> ;Annals of Internal Medicine. 2022 Oct 1
56 citations
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.
Maves, R., Wang, J. P., Castro, J. G., Yang, O. O., Cameron R Wolfe, Kay M Tomashek, Thomas F Patterson, Carlos A Gomez, Vincent C Marconi, Mamta K Jain, Otto O Yang, ...> ;The Lancet. Respiratory Medicine. 2022 Sep 1
1 citations
Principles for Ending Human Immunodeficiency Virus as an Epidemic in the United States: A Policy Paper of the Infectious Diseases Society of America and the HIV Medica...
Anna K Person, Wendy S Armstrong, Tyler Evans, John J W Fangman, Robert H Goldstein, Marwan Haddad, Mamta K Jain, Susana Keeshin, Hansel E Tookes, Andrea L Weddle, Jud...> ;Clinical Infectious Diseases. 2023 Jan 6
2 citations
Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO).
Eleftherios Mylonakis, Joseph Lutaakome, Mamta K Jain, Angela J Rogers, José Moltó, Susana Benet, Ahmad Mourad, D Clark Files, Henry Mugerwa, Cissy Kityo, Francis Kiwe...> ;Med. 2022 Aug 12
1 citations
HBV transcription and translation persist despite viral suppression in HBV-HIV co-infected patients on antiretroviral therapy.
Mauricio Lisker-Melman, Abdus S Wahed, Marc G Ghany, Raymond T Chung, Wendy C King, David E Kleiner, Atul K Bhan, Mandana Khalili, Mamta K Jain, Mark Sulkowski, David ...> ;Hepatology. 2023 Feb 1
A Multicomponent Intervention to Reduce Readmissions Among People With HIV.
Ank E Nijhawan, Song Zhang, Matthieu Chansard, Ang Gao, Mamta K Jain, Ethan A Halm> ;Journal of Acquired Immune Deficiency Syndromes. 2022 Jun 1
Erratum to: Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of Amer...
Melanie A Thompson, Michael A Horberg, Allison L Agwu, Jonathan A Colasanti, Mamta K Jain, William R Short, Tulika Singh, Judith A Aberg> ;Clinical Infectious Diseases. 2022 May 30
1 citations
A prospective cohort study of renal function and bone turnover in adults with hepatitis B virus (HBV)-HIV co-infection with high prevalence of tenofovir-based antiretr...
Andinet Gizaw, Wendy C King, Amanda S Hinerman, Raymond T Chung, Mauricio Lisker-Melman, Marc G Ghany, Mandana Khalili, Mamta K Jain, Jacob Graham, Theresa Swift-Scanl...> ;HIV Medicine. 2023 Jan 1
6 citations
Patient Navigation Increases Linkage to Care and Receipt of Direct-acting Antiviral Therapy in Patients with Hepatitis C.
Joslyn Strebe, Nicole E Rich, Li Wang, Amit G Singal, Jennifer McBryde, Mauro Silva, Hannah Fullington, Deyaun L Villarreal, Stephanie Reyes, Bertha Flores, Mamta K Ja...> ;Clinical Gastroenterology and Hepatology. 2023 Apr 1
1 citations
Predictors of linkage to hepatitis C virus care among people living with HIV with hepatitis C infection and the impact of loss to HIV follow-up.
Abby A Lau, Joslyn K Strebe, Teena V Sura, Laura A Hansen, Mamta K Jain> ;Health Science Reports. 2022 May 1
44 citations
Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial.
, Lundgren, J., Grund, B., Barkauskas, C., Holland, T., Gottlieb, R., Sandkovsky, U., Brown, S., Knowlton, K., Self, W., Files, D., Jain, M., Benfield, T., Bowdish, M....> ;Annals of Internal Medicine. 2022 Feb 1
3 citations
Atovaquone for treatment of COVID-19: A prospective randomized, double-blind, placebo-controlled clinical trial.
Mamta K Jain, James A De Lemos, Darren K McGuire, Colby Ayers, Jennifer L Eitson, Claudia L Sanchez, Dena Kamel, Jessica A Meisner, Emilia V Thomas, Anita A Hegde, Sat...> ;Frontiers in Pharmacology. 2022 Jan 1
2 citations
A Prospective Cohort Study of Novel Markers of Hepatitis B Virus Replication in Human Immunodeficiency Virus Coinfection.
Raymond T Chung, Wendy C King, Marc G Ghany, Mauricio Lisker-Melman, Amanda S Hinerman, Mandana Khalili, Mark Sulkowski, Mamta K Jain, Eun-Young K Choi, Michael A Nale...> ;Clinical Gastroenterology and Hepatology. 2023 Jan 1
8 citations
Infectious Diseases Society of America Guidelines on Infection Prevention for Healthcare Personnel Caring for Patients with Suspected or Known COVID-19.
John B Lynch, Perica Davitkov, Deverick J Anderson, Adarsh Bhimraj, Vincent Chi-Chung Cheng, Judith Guzman-Cottrill, Jasmine Dhindsa, Abhijit Duggal, Mamta K Jain, Gra...> ;Clinical Infectious Diseases. 2021 Nov 15
Evolution of Fatty Liver Disease and Relationship With Lipoproteins and Clinical Outcomes in Hepatitis B/Human Immunodeficiency Virus Coinfection.
Mandana Khalili, Wendy C. King, David E. Kleiner, Raymond T. Chung, Atul K. Bhan, Marc G. Ghany, Mark S. Sulkowski, Mauricio Lisker-Melman, Mamta K. Jain, Harry L.A. J...> ;Clinical Infectious Diseases. 2021 Oct 25
96 citations
Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phas...
Andre C. Kalil, Aneesh K. Mehta, Thomas F Patterson, Nathaniel B. Erdmann, Carlos A. Gomez, Mamta K. Jain, Cameron R. Wolfe, Guillermo M. Ruiz-Palacios, Susan Kline, J...> ;The Lancet. Respiratory Medicine. 2021 Oct 18
6 citations
Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems.
Robert J Wong, Mamta K Jain, George Therapondos, Bolin Niu, Onkar Kshirsagar, Mae Thamer> ;The American Journal of Gastroenterology. 2021 Mar 1
10 citations
A Prospective Study Evaluating Changes in Histology, Clinical and Virologic Outcomes in HBV-HIV Co-infected Adults in North America.
Richard K. Sterling, Wendy C. King, Mandana Khalili, Raymond T. Chung, Mark S. Sulkowski, Mamta K. Jain, Mauricio Lisker-Melman, Marc G. Ghany, David Wong, Amanda Hine...> ;Hepatology. 2021 Sep 1
4 citations
Care Facilitation Advances Movement Along the Hepatitis C Care Continuum for Persons With Human Immunodeficiency Virus, Hepatitis C, and Substance Use: A Randomized Cl...
Lisa R. Metsch, Daniel J. Feaster, Lauren Gooden, Carmen L. Masson, David C. Perlman, Mamta K. Jain, Tim Matheson, C. Mindy Nelson, Petra Jacobs, Susan Tross, Louise H...> ;Open Forum Infectious Diseases. 2021 Aug 1
6 citations
Incidence and Predictors of Hepatitis B Surface Antigen Clearance in HIV Patients: A Retrospective Multisite Study.
Mamta K. Jain, Karen J Vigil, Paul Parisot, Gabriella Go, Trung Vu, Xilong Li, Laura Hansen, Barbara S. Taylor> ;Open Forum Infectious Diseases. 2021 Apr 16
6 citations
Low Rates of Hepatitis B Virus Treatment Among Treatment-Eligible Patients in Safety-Net Health Systems.
Robert J. Wong, Mamta K. Jain, George Therapondos, Bolin Niu, Onkar Kshirsagar, Mae Thamer> ;Journal of Clinical Gastroenterology. 2021 Mar 17
Join now to see all

Journal Articles

Spectrum of Liver Disease in Hepatitis B Virus (HBV) Patients Co-Infected with Human Immunodeficiency Virus (HIV): Results of the HBV-HIV Cohort Study
Mandana Khalili, Mark Sulkowski, Marc G Ghany, Richard K Sterling, Raymond T Chung, David E Kleiner, Mamta K Jain, Nature
Has Access to HCV Therapy Changed for Patients with Mental Health or Substance Use Disorders in the DAA Period?
Mamta K Jain, Mitchell L Shiffman, Hepatology